Announces MydCombi expected PDUFA date of October 28, 2021 Completes patient enrollment in Phase 3 VISION-1 study evaluating MicroLine for the treatment of presbyopia; topline data on track for Q2 Company to host conference call and webcast today, March 25, at 4:30 pm ET NEW YORK, March 25, 2021
March 25, 2021
· 12 min read